156 related articles for article (PubMed ID: 25533581)
41. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis.
Peterson D; McLeod S; Woolfrey K; McRae A
Acad Emerg Med; 2014 May; 21(5):526-31. PubMed ID: 24842503
[TBL] [Abstract][Full Text] [Related]
42. Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer.
De la Maza V; Simian D; Castro M; Torres JP; Lucero Y; Sepúlveda F; Mazquiaran S; Salazar C; Segovia L; Santolaya ME
Pediatr Infect Dis J; 2015 Oct; 34(10):1069-73. PubMed ID: 26125587
[TBL] [Abstract][Full Text] [Related]
43. Morbidity and mortality revisited: applying a new quality improvement paradigm in oncology.
Stover DG; Zerillo JA
J Oncol Pract; 2015 May; 11(3):e428-33. PubMed ID: 25901054
[TBL] [Abstract][Full Text] [Related]
44. Standardized process used in the emergency department for pediatric oncology patients with fever and neutropenia improves time to the first dose of antibiotics.
Cash T; Deloach T; Graham J; Shirm S; Mian A
Pediatr Emerg Care; 2014 Feb; 30(2):91-3. PubMed ID: 24457498
[TBL] [Abstract][Full Text] [Related]
45. [Febrile neutropenia at the emergency department of a cancer hospital].
Debey C; Meert AP; Berghmans T; Thomas JM; Sculier JP
Rev Med Brux; 2011; 32(2):74-82. PubMed ID: 21688591
[TBL] [Abstract][Full Text] [Related]
46. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.
Ko BS; Ahn S; Lee YS; Kim WY; Lim KS; Lee JL
Support Care Cancer; 2015 Sep; 23(9):2799-804. PubMed ID: 25663578
[TBL] [Abstract][Full Text] [Related]
47. History and outcome of febrile neutropenia related to non-chemotherapy drugs: A retrospective study of the Strasbourg's agranulocytosis cohort.
Andrès E; Mourot-Cottet R; Maloisel F; Vogel T; Tebacher M; Gottenberg JE
Eur J Intern Med; 2017 Dec; 46():e13-e14. PubMed ID: 28823525
[No Abstract] [Full Text] [Related]
48. Management of febrile neutropenia in pediatric oncology across Queensland, Australia: a retrospective review on variations between locations.
Cox A; Bradford N
J Pediatr Oncol Nurs; 2014; 31(1):28-33. PubMed ID: 24378817
[TBL] [Abstract][Full Text] [Related]
49. Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.
Salstrom JL; Coughlin RL; Pool K; Bojan M; Mediavilla C; Schwent W; Rannie M; Law D; Finnerty M; Hilden J
Pediatr Blood Cancer; 2015 May; 62(5):807-15. PubMed ID: 25663663
[TBL] [Abstract][Full Text] [Related]
50. Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.
Butts AR; Bachmeier CC; Dressler EV; Liu M; Cowden A; Talbert J; Adams VR
J Oncol Pharm Pract; 2017 Jun; 23(4):278-283. PubMed ID: 28077045
[TBL] [Abstract][Full Text] [Related]
51. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
52. The impact of evidence-based sepsis guidelines on emergency department clinical practice: a pre-post medical record audit.
Romero B; Fry M; Roche M
J Clin Nurs; 2017 Nov; 26(21-22):3588-3596. PubMed ID: 28071865
[TBL] [Abstract][Full Text] [Related]
53. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
[TBL] [Abstract][Full Text] [Related]
54. Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India.
Noronha V; Joshi A; Patil VM; Bhosale B; Muddu VK; Banavali S; Kelkar R; Prabhash K
Indian J Cancer; 2014; 51(4):470-4. PubMed ID: 26842166
[TBL] [Abstract][Full Text] [Related]
55. Is parenteral chemotherapy safe in rural hospitals? A prospective audit of neutropenic fever in Albany Hospital, a regional West Australian cancer centre.
Kennedy K; Auret K
Intern Med J; 2017 Feb; 47(2):177-182. PubMed ID: 27753283
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
57. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
Corey AL; Snyder S
J Pediatr Oncol Nurs; 2008; 25(4):208-12. PubMed ID: 18539908
[TBL] [Abstract][Full Text] [Related]
58. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
Vedi A; Cohn R
J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
[TBL] [Abstract][Full Text] [Related]
59. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
Donohue R
Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
[TBL] [Abstract][Full Text] [Related]
60. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
